ClinicalTrials.Veeva

Menu

Association Between Mitochondrial DNA Content and Risk of Gastric Cancer

A

Air Force Military Medical University of People's Liberation Army

Status

Completed

Conditions

Stomach Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT02944539
ZJ20161024

Details and patient eligibility

About

Compelling epidemiological evidence indicates that alterations of mitochondrial DNA, including mutations and abnormal content of mitochondrial DNA (mtDNA), are associated with the initiation and development of gastric cancer.The aim of this study was to explore association between mtDNA content in peripheral blood cells could be used as a risk predictor for gastric cancer.

Enrollment

600 patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 1.histological confirmed gastric adenocarcinoma; 2.receiving surgical resection; 3.no preoperative anticancer treatment; 4.alive at least 1 months after surgery.

Exclusion criteria

  • 1.history of other malignancy; 2.blood transfusion within one month or prior bone marrow transplantation; 3.patients who reluctant to sign informed consent.

Trial design

600 participants in 2 patient groups

Gastric cancer group
Description:
300 consecutive patients were recruited, who have diagnosed with gastric cancer by biopsy
Control group
Description:
The 300 healthy controls without previous cancer history were recruited from individuals who visited investigator's hospital for physical examination during the same time period as the case enrollment.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems